133 related articles for article (PubMed ID: 11302748)
1. Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT(1) receptor.
Conway S; Mowat ES; Drew JE; Barrett P; Delagrange P; Morgan PJ
Biochem Biophys Res Commun; 2001 Apr; 282(5):1229-36. PubMed ID: 11302748
[TBL] [Abstract][Full Text] [Related]
2. Mapping the melatonin receptor. 6. Melatonin agonists and antagonists derived from 6H-isoindolo[2,1-a]indoles, 5,6-dihydroindolo[2,1-a]isoquinolines, and 6,7-dihydro-5H-benzo[c]azepino[2,1-a]indoles.
Faust R; Garratt PJ; Jones R; Yeh LK; Tsotinis A; Panoussopoulou M; Calogeropoulou T; Teh MT; Sugden D
J Med Chem; 2000 Mar; 43(6):1050-61. PubMed ID: 10737738
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of human melatonin mt(1) and MT(2) receptors by CRE-luciferase reporter assay.
Conway S; Canning SJ; Howell HE; Mowat ES; Barrett P; Drew JE; Delagrange P; Lesieur D; Morgan PJ
Eur J Pharmacol; 2000 Feb; 390(1-2):15-24. PubMed ID: 10708702
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological characterization of human recombinant melatonin mt(1) and MT(2) receptors.
Browning C; Beresford I; Fraser N; Giles H
Br J Pharmacol; 2000 Mar; 129(5):877-86. PubMed ID: 10696085
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.
Teh MT; Sugden D
Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):522-8. PubMed ID: 9840420
[TBL] [Abstract][Full Text] [Related]
6. Chimeric melatonin mt1 and melatonin-related receptors. Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt1 receptor.
Conway S; Drew JE; Mowat ES; Barrett P; Delagrange P; Morgan PJ
J Biol Chem; 2000 Jul; 275(27):20602-9. PubMed ID: 10770942
[TBL] [Abstract][Full Text] [Related]
7. Design of subtype selective melatonin receptor agonists and antagonists.
Sugden D; Yeh LK; Teh MT
Reprod Nutr Dev; 1999; 39(3):335-44. PubMed ID: 10420436
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors.
Lai FP; Mody SM; Yung LY; Kam JY; Pang CS; Pang SF; Wong YH
J Neurochem; 2002 Mar; 80(5):736-45. PubMed ID: 11948236
[TBL] [Abstract][Full Text] [Related]
9. Mutagenesis studies of the human MT2 melatonin receptor.
Gerdin MJ; Mseeh F; Dubocovich ML
Biochem Pharmacol; 2003 Jul; 66(2):315-20. PubMed ID: 12826274
[TBL] [Abstract][Full Text] [Related]
10. Receptor (MT(1)) mediated influence of melatonin on cAMP concentration and insulin secretion of rat insulinoma cells INS-1.
Peschke E; Mühlbauer E; Musshoff U; Csernus VJ; Chankiewitz E; Peschke D
J Pineal Res; 2002 Sep; 33(2):63-71. PubMed ID: 12153439
[TBL] [Abstract][Full Text] [Related]
11. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor.
Dubocovich ML; Masana MI; Iacob S; Sauri DM
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):365-75. PubMed ID: 9089668
[TBL] [Abstract][Full Text] [Related]
12. Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits.
Pintor J; Martin L; Pelaez T; Hoyle CH; Peral A
Eur J Pharmacol; 2001 Mar; 416(3):251-4. PubMed ID: 11290376
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated modulation of avian caecal muscle contraction by melatonin: role of tyrosine protein kinase.
Poon AM; Kravtsov GM; Pang SF
J Pineal Res; 2002 Apr; 32(3):199-208. PubMed ID: 12074105
[TBL] [Abstract][Full Text] [Related]
14. Chimeric and point-mutated receptors reveal that a single glycine residue in transmembrane domain 6 is critical for high affinity melatonin binding.
Gubitz AK; Reppert SM
Endocrinology; 2000 Mar; 141(3):1236-44. PubMed ID: 10698201
[TBL] [Abstract][Full Text] [Related]
15. Mapping the melatonin receptor. 5. Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles.
Davies DJ; Garratt PJ; Tocher DA; Vonhoff S; Davies J; Teh MT; Sugden D
J Med Chem; 1998 Feb; 41(4):451-67. PubMed ID: 9484496
[TBL] [Abstract][Full Text] [Related]
16. Melatonin receptor pharmacology: toward subtype specificity.
Sugden D; Pickering H; Teh MT; Garratt PJ
Biol Cell; 1997 Nov; 89(8):531-7. PubMed ID: 9618903
[TBL] [Abstract][Full Text] [Related]
17. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
Pauwels PJ; Colpaert FC
Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
[TBL] [Abstract][Full Text] [Related]
18. Differential coupling of the extreme C-terminus of G protein alpha subunits to the G protein-coupled melatonin receptors.
Drew JE; Barrett P; Conway S; Delagrange P; Morgan PJ
Biochim Biophys Acta; 2002 Oct; 1592(2):185-92. PubMed ID: 12379482
[TBL] [Abstract][Full Text] [Related]
19. 2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists.
Spadoni G; Balsamini C; Bedini A; Diamantini G; Di Giacomo B; Tontini A; Tarzia G; Mor M; Plazzi PV; Rivara S; Nonno R; Pannacci M; Lucini V; Fraschini F; Stankov BM
J Med Chem; 1998 Sep; 41(19):3624-34. PubMed ID: 9733487
[TBL] [Abstract][Full Text] [Related]
20. A new melatonin receptor ligand with mt1-agonist and MT2-antagonist properties.
Nonno R; Lucini V; Spadoni G; Pannacci M; Croce A; Esposti D; Balsamini C; Tarzia G; Fraschini F; Stankov BM
J Pineal Res; 2000 Nov; 29(4):234-40. PubMed ID: 11068946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
